The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Official Title: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Study ID: NCT04108936
Brief Summary: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Detailed Description: Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome. Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome. Analysis of renal function with respect of different HIPEC regimens Identification of clinical surrogate parameters for outcome.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Krankenhaus der Barmherzigen Brüder Regensburg, Regensburg, Bavaria, Germany
University Hospital Regensburg, Regensburg, , Germany
Name: Matthias Hornung, MD
Affiliation: Dept. of Surgery, University Hospital Regensburg
Role: STUDY_DIRECTOR
Name: Jens M Werner, MD
Affiliation: Dept. of Surgery, University Hospital Regensburg
Role: PRINCIPAL_INVESTIGATOR